Ignyta, Inc.
DelistedCIK 1557421fmd_0M2RQ4P0XFJGZX2K438F5W9Q88Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2011 to Sep 30, 2017, 26 periods
| Line item | FY2011 | FY2012 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | 0 | – | – |
| Research and development | – | – | 1 | 10 | 31 | 74 | 77 |
| Total operating expenses | – | (0) | – | – | 40 | 91 | 101 |
| Operating income | – | – | (1) | (14) | (40) | (91) | (101) |
| Interest expense | – | – | 0 | 0 | 1 | 3 | 3 |
| Interest and investment income | – | – | – | – | 1 | 1 | 1 |
| Other non-operating income (expense) | – | – | (0) | (0) | (0) | (2) | (3) |
| Income before taxes | – | – | (1) | (14) | (40) | – | – |
| Income tax expense | – | – | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | – | (0) | – | (14) | (40) | – | – |
| Net income | (0) | – | (1) | (14) | (40) | (92) | (104) |